BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33282058)

  • 1. Overcoming COVID-19 in West African countries: is herd immunity an option?
    Ilesanmi OS; Akande A; Afolabi AA
    Pan Afr Med J; 2020; 35(Suppl 2):103. PubMed ID: 33282058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can Africa achieve herd immunity?
    Lucero-Prisno DE; Ogunkola IO; Esu EB; Adebisi YA; Lin X; Li H
    Glob Health Res Policy; 2021 Dec; 6(1):46. PubMed ID: 34852844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 herd immunity in the absence of a vaccine: an irresponsible approach.
    Khalife J; VanGennep D
    Epidemiol Health; 2021; 43():e2021012. PubMed ID: 33541010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herd immunization with childhood vaccination may provide protection against COVID-19.
    Yu Y
    Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achieving herd immunity against COVID-19 at the country level by the exit strategy of a phased lift of control.
    de Vlas SJ; Coffeng LE
    Sci Rep; 2021 Feb; 11(1):4445. PubMed ID: 33627674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunity against SARS-CoV-2: walking to the vaccination].
    Rodríguez Hernández C; Sanz Moreno L
    Rev Esp Quimioter; 2020 Dec; 33(6):392-398. PubMed ID: 32935536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herd Immunity Against Coronavirus: A Review.
    Datta S; Roy A
    Recent Pat Biotechnol; 2022 Aug; 16(3):256-265. PubMed ID: 35400332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Herd Immunity to COVID-19 in Louisiana Nursing Homes.
    Reilly TA
    J Am Med Dir Assoc; 2021 Feb; 22(2):256-257. PubMed ID: 33358724
    [No Abstract]   [Full Text] [Related]  

  • 9. Population Immunity Against COVID-19 in the United States.
    Moghadas SM; Sah P; Shoukat A; Meyers LA; Galvani AP
    Ann Intern Med; 2021 Nov; 174(11):1586-1591. PubMed ID: 34516275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to Understand Herd Immunity in the Context of COVID-19.
    Dong M; He F; Deng Y
    Viral Immunol; 2021 Apr; 34(3):174-181. PubMed ID: 33351708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges of vaccination and herd immunity in COVID-19 and management strategies.
    She J; Hou D; Chen C; Bi J; Song Y
    Clin Respir J; 2022 Nov; 16(11):708-716. PubMed ID: 36172975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects.
    Wong RSY
    Malays J Pathol; 2021 Aug; 43(2):203-217. PubMed ID: 34448786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of vaccination on the COVID-19 pandemic in U.S. states.
    Chen X; Huang H; Ju J; Sun R; Zhang J
    Sci Rep; 2022 Jan; 12(1):1554. PubMed ID: 35091640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bumpy road to achieve herd immunity in COVID-19.
    Neagu M
    J Immunoassay Immunochem; 2020 Nov; 41(6):928-945. PubMed ID: 33086932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herd Immunity and Implications for SARS-CoV-2 Control.
    Omer SB; Yildirim I; Forman HP
    JAMA; 2020 Nov; 324(20):2095-2096. PubMed ID: 33074293
    [No Abstract]   [Full Text] [Related]  

  • 16. The Effect of Vaccination Rates on the Infection of COVID-19 under the Vaccination Rate below the Herd Immunity Threshold.
    Chen YT
    Int J Environ Res Public Health; 2021 Jul; 18(14):. PubMed ID: 34299942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The devil in the details: Herd immunity and pandemic response.
    Schaeffer B; Taylor B; Bushman M; Hanage WP
    Cell Host Microbe; 2021 Jul; 29(7):1048-1051. PubMed ID: 34265244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaching Herd Immunity During the SARS-CoV-2 Pandemic: What School Nurses Need to Know.
    Barnby E; Reynolds M; Gordon J
    NASN Sch Nurse; 2022 Jan; 37(1):13-18. PubMed ID: 34836470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19: Is herd immunity the only option for fragile Yemen?
    Noushad M; Al-Saqqaf IS
    Int J Infect Dis; 2021 May; 106():79-82. PubMed ID: 33737135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could COVID-19 be contained in poor populations by herd immunity rather than by strategies designed for affluent societies or potential vaccine(s)?
    Ruppel A; Halim MI; Kikon R; Mohamed NS; Saebipour MR
    Glob Health Action; 2021 Jan; 14(1):1863129. PubMed ID: 33397199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.